News
28
2018-06
23rd-24th June 2018, The Third China Summit for Retrograde Percutaneous Recanalization of Chronic Total Occlusion (RPR-CTO Summit 2018), which was hosted by Guangdong Medical Doctor Association and Guangdong Interventional Cardiology Association and organized by Guangdong People’ Hospital, was successfully convened at Dong Fang Hotel, Guangzhou China.
2018-06-28
03
2018-05
BrosMed Medical Announces Completes Successful FDA Inspection
Brosmed, Dongguan., April 28, 2018–Brosmed Medical Co. ,Ltd, a leading provider of medical device of cardiovascular and endovascular since 2012, is pleased to announce it successfully completed 4 days Quality System/Current Good Manufacturing Practice regulations for medical devices (21 CFR Part 820) inspection from FDA. This comes as a result of Brosmed medical 5 years ongoing commitment to the highest levels of quality standards.
2018-05-03
11
2018-01
BrosMed Medical Announces CE Mark and Launch of Wedge™ Semi-complaint Scoring PTCA
BrosMed Medical Announces CE Mark and Launch of Wedge™ Semi-complaint Scoring PTCA October 27th, 2017—BrosMed Medical announced CE Mark and Launched its Wedge™ Scoring PTCA Balloon for the treatment of percutaneous transluminal coronary angioplasty (PTCA) for the purpose of improving myocardial blood flow in the localized stenotic lesion of the coronary arteries.
2018-01-11
30
2017-08
BrosMed Medical Announces Japanese Approval and Launch of Artimes™ and Apollo™ PTCA In Japan Market
BrosMed Medical Announces Japanese Approval and Launch of Artimes™ and Apollo™ PTCA In Japan Market Aug 30th , 2017—BrosMed Medical announces Japan PMDA approval of its Artimes™ and Apollo™ PTCA balloons, and formally launches in Japan.
2017-08-30
02
2017-04
BrosMed Announces Strategic Agreement with Cardinal Health
BrosMed Announces Strategic Agreement with Cardinal Health March 31st, 2017 in CIT 2017 Beijing China — BrosMed announced that it has entered into a strategic distribution agreement with Cardinal Health.
2017-04-02
14
2016-12
BrosMed Announces FDA 510(k) Clearance and Launch of Hermes™ NC 0.035 OTW PTA, Achilles™ NC 0.018 OTW PTA and Castor™ NC 0.014 OTW PTA Balloon Dilatation Catheters December 14, 2016—BrosMed announced FDA 510(k) clearance and launch its Hermes™ NC 0.035 OTW PTA, Achilles™ NC 0.018 OTW PTA and Castor™ NC 0.014 OTW percutaneous
2016-12-14
08
2016-08
BrosMed Announces FDA 510(k) Clearance and Launch of Additonal Configurations Apollo™ NC PTCA Balloon Catheters in Unitied States and North Amercia Market
2016-08-08
13
2016-03
BrosMed Announces CE Mark and Launch for Conger™ Hydrophilic Coated Wire
BrosMed Announces CE Mark and Launch for Conger™ Hydrophilic Coated Wire March 15, 2016—BrosMed announced CE Mark and Launch of its Conger™ hydrophilic coated wire for peripheral vasculature during diagnostic and interventional procedures.
2016-03-13